 NDI is a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to:
- Address significant unmet health conditions
- Improve patients’ lives
- Provide significant returns to investors
Founded in 2002, NDI has a proven track record of moving technology from innovation to commercialization to profitability.
NDI leverages its platform of innovative technologies to commercialize an extensive pipeline of neurotech opportunities, creating high-growth portfolio companies
In April 2008, NDI sold its first portfolio company to Medtronic Inc. for $42 million, returning over 150 times the original investment back to investors.
NDI is headquartered in Cleveland, Ohio – one of the world’s centers of neurodevice research and innovation.
NDI’s leadership team has a long history of working together, and includes seasoned medical device and investment professionals, scientists, physician advisors and experts in clinical, regulatory, production development, operations and finance for the neurodevice industry.
|